Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Lamivudine 150 mg Tablet, film coated Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom 3TC Lamivudine 10 mg/mL Solution, oral Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom 3TC Aspirin 25 mg, dipyridamole 200 mg Capsule, modified release Boehringer Ingelheim Pharma KG., Biberach an der Riss, Germany and Boehringer Ingelheim Pharma KG., Ingelheim am Rhein, Germany Asasantin Retard Clotrimazole 1%, 2% Cream, vaginal Taro Pharmaceuticals Inc., Bramelea, Ontario, Canada Clotrimaderm Clotrimazole 1% Cream, topical Taro Pharmaceuticals Inc., Bramelea, Ontario, Canada Clotrimazole Felodipine 5 mg, metoprolol succinate 47.5 mg equivalent to 50 mg metoprolol tartrate; felodipine 10 mg, metoprolol succinate 95 mg equivalent to 100 mg metoprolol tartrate Tablets, modified release Astra Pharmaceutical Production AB., Sodertalje, Sweden Logimax Fluvoxamine maleate 50 mg, 100 mg Tablets, film coated Solvay Duphar BV., Olst, The Netherlands Luvox Vinorelbine tartrate 13.85 mg/mL equivalent to 10 mg/mL vinorelbine Injection, solution Aquitaine Pharm International, Pierre Fabre Medicament Subsidiary, Idron, France Navelbine Grepafloxacin hydrochloride sesquihydrate 236.4 mg equivalent to 200 mg grepafloxacin Tablet, film coated Otsuka Pharmaceutical Co Limited, Tokushima-shi, Tokushima, Japan Raxar Grepafloxacin hydrochloride sesquihydrate 472.8 mg, 709.2 mg equivalent to 400 mg, 600 mg grepafloxacin Tablets, film coated Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom Raxar Salbutamol sulphate 60 g/dose equivalent to 50 g/dose salbutamol Inhalation powder Astra Pharmaceutical Production AB, Sodertalje, Sweden Salbutamol Turbuhaler Topiramate 25 mg, 50 mg, 100 mg, 200 mg, 300 mg, 400 mg Tablet, film coated Janssen-Cilag Farmaceutica LDA., Queluz de Baixo, Queluz, Portugal Topamax Daclizumab 5mg/mL Infusion, concentrate Hoffmann-La Roche Inc., Nutley, New Jersey, United States of America Zenapax Zolmitriptan 2.5 mg, 5 mg Tablets, film coated IPR Pharmaceuticals Inc., Carolina, San Juan, Puerto Rico Zomig Dated this 5th day of June 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.